“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Cutaneous T-cell lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that affects the skin. It is characterized by the abnormal growth and accumulation of T cells (a type of white blood cell) in the skin.
The most common symptoms of CTCL are:
There are several subtypes of CTCL, including mycosis fungoides and Sézary syndrome, which are differentiated by the appearance of skin lesions, the extent of skin involvement, and the presence of abnormal T cells in the blood.
Treatment for CTCL depends on the subtype and stage of the disease. Treatment options may include:
Overall, the prognosis for CTCL varies depending on the subtype and stage of the disease, with early-stage cases generally having a better prognosis than advanced cases. It is important for individuals with CTCL to work closely with their healthcare provider to develop an individualized treatment plan and manage their symptoms effectively.